Ikena Oncology™ discovers and develops patient-directed therapies for cancer patients who need life-saving treatment, by understanding what drives their disease.Learn More
Making it personal to change what’s possible.
Discovering and developing patient-directed therapies for cancer patients by understanding what drives their disease.Learn More
Pioneering Biomarker-Driven Oncology Therapeutics
Ikena™ is a translational science-driven company developing breakthrough targeted oncology and immunometabolism therapies for difficult to treat cancers. IKENA™ APPROACH
Pioneering Biomarker-Driven Oncology Therapeutics
Ikena™ is developing breakthrough targeted oncology and immunometabolism therapies for difficult to treat cancers. IKENA™ APPROACH
Innovating for Our Patients
At Ikena, our novel pipeline includes programs across distinct molecular targets and biologic pathways modulating both the immune system and the tumor.VIEW OUR PIPELINE
Innovating for Our Patients
Our pipeline includes programs across distinct molecular targets and biologic pathways modulating both the immune system and the tumor.VIEW OUR PIPELINE
